Open access peer-reviewed Edited Volume

Recent Update on Multiple Myeloma

Khalid Al-Anazi

King Fahad Specialist Hospital

Dr. Khalid Al-Anazi established the Hematopoietic Stem Cell Transplantation Services in Saudi Arabia. He is a distinguished researcher in the fields of stem cell therapies & infections in immunocompromised individuals.

Covering

Risk Factors Angiogenesis Signaling Pathways Therapeutic Targets Drug Resistance Genetic Mutations Disease-Related Infections Therapy-Related Infections Complete Remission Overall Survival Immunomodulatory Agents Bone Marrow Microenvironment

Register your interest in contributing to this book

Collaborate with our community and contribute your knowledge.

About the book

The book will be a recent update on multiple myeloma. It will aim to include several chapters covering various aspects of multiple myeloma including:
Diagnosis (clinical, radiological, cytogenetic, and molecular criteria), pathogenesis (risk factors, pre-myeloma conditions, and bone marrow microenvironment), cytogenetic abnormalities and molecular profiles disease staging and risk stratification, novel therapies such as proteasome inhibitors, immunomodulatory agents as well as monoclonal antibodies, drug resistance (primary and secondary resistance as well as evolution of new genetic mutations that may be disease or therapy-related), hematopoietic stem cell transplantation (HSCT) (autologous HSCT, allogeneic HSCT, and tandem transplantation), relapsed and refractory multiple myeloma, minimal residual disease (evaluation by flow cytometry or various sequencing techniques, importance of MRD in prognosis and prediction of disease relapse), chimeric antigen receptor (CAR) T-cell therapy, infectious complications in multiple myeloma (viral infections, bacterial infections, fungal infections, disease-related infections and therapy-related infections).

The book chapters will intend to be written by scientists and experts in the field from various institutions around the world.

Publishing process

Book initiated and editor appointed

Date completed: January 26th 2022

Applications to edit the book are assessed and a suitable editor is selected, at which point the process begins.

Chapter proposals submitted and reviewed

Deadline Extended: Open for Submissions

Potential authors submit chapter proposals ready for review by the academic editor and our publishing review team.

Approved chapters written in full and submitted

Deadline for full chapters: May 28th 2022

Once approved by the academic editor and publishing review team, chapters are written and submitted according to pre-agreed parameters

Full chapters peer reviewed

Review results due: August 16th 2022

Full chapter manuscripts are screened for plagiarism and undergo a Main Editor Peer Review. Results are sent to authors within 30 days of submission, with suggestions for rounds of revisions.

Book compiled, published and promoted

Expected publication date: October 15th 2022

All chapters are copy-checked and typesetted before being published. IntechOpen regularly submits its books to major databases for evaluation and coverage, including the Clarivate Analytics Book Citation Index in the Web of ScienceTM Core Collection. Other discipline-specific databases are also targeted, such as Web of Science's BIOSIS Previews.

About the editor

Khalid Al-Anazi

King Fahad Specialist Hospital

Dr. Khalid Ahmed Al-Anazi is a consultant Hemato-Oncologist and the Chairman of the Department of Adult Hematology and Hematopoietic Stem Cell Transplantation (HSCT) at King Fahad Specialist Hospital (KFSH) in Dammam, Saudi Arabia. He graduated from the college of medicine, King Saud University (KSU) in Riyadh in 1986. After having his Boards in Internal Medicine, he trained in clinical hematology and HSCT at King’s College Hospital, University of London, U.K. He has 4 year experience in internal medicine and 28 year experience in adult clinical hematology and HSCT at: Riyadh Armed Forces Hospital; King Faisal Specialist Hospital and Research Centre (KFSH&RC) in Riyadh; King Khalid University Hospital (KKUH) and the College of Medicine, KSU in Riyadh; and KFSH in Dammam, Saudi Arabia. He established the adult HSCT program at KFSH in Dammam in the year 2010. He received the award of the best teacher in the Department of Medicine, at the College of Medicine and KKUH in Riyadh in the year 2014. He has more than 95 publications including retrospective studies, review articles, book chapters, and electronic books and he is a reviewer for 25 international medical journals. He is the Editor-in-Chief of the Journal of Stem Cell Biology and Transplantation and the Journal of Molecular Genetics and Medicine in addition to being Associate Editor for 26 other medical journals in HSCT, hematology, cancer and infectious diseases. He is a member of several international organizations including ECIL (European Conference of Infections in Leukemia).

View profile

Book chapters authored 10

Books edited 2

Introducing your Author Service Manager

Ms. Paula Gavran

Ask a question
creativecommons
alpsp
cope
stm
ithenticate
crossref
doi
oaspa

Book will be abstracted and indexed in

googlescholar
worldcat
base
az
openaire